Argos Therapeutics

Argos Therapeutics, Inc. is a biotechnology company dedicated to immunotherapy for cancer, infectious diseases, autoimmune diseases, and transplant rejection. The company has clinical trial programs for cancer and human immunodeficiency virus (HIV). Its products include AGS-0031 for the treatment of metastatic renal cell carcinoma; AGS-0041 for the treatment of HIV; CD83 soluble protein for transplant rejection/autoimmune diseases; anti-IFN-alpha monoclonal antibody for systemic lupus erythematosus; and regulatory T-cell therapy for autoimmune diseases.